NDC 64679-067-01 - Decitabine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64679-067
- Requested NDC
- 64679-067-01
- Package NDCs from labels
- 64679-067-01, 64679-067-02
- Manufacturer
- Wockhardt USA LLC. | Wockhardt Limited | Shilpa Medicare Limited
- Effective date
- 2020-11-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Decitabine - Wockhardt USA LLC. | Wockhardt Limited | Shilpa Medicare Limited | Wockhardt USA LLC. | Wockhardt Limited | Shilpa Medicare Limited | 2020-11-17 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Decitabine | DECITABINE | Northstar Rx LLC | 1abbe952-58bc-4dbc-b06a-fb79167bcd66 | 2020-08-17 | Warnings, Adverse reactions | 776B62CQ27 |
| Decitabine | DECITABINE | Novadoz Pharmaceuticals LLC | ae6c4580-3a3a-4c42-903a-1565d79521f8 | 2020-08-01 | Warnings, Adverse reactions | 776B62CQ27 |
| Decitabine | DECITABINE | Mylan Institutional LLC | 447a9fbd-106d-4ff6-8fd0-bb38a8c90e17 | 2020-07-26 | Warnings, Adverse reactions | 776B62CQ27 |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 4J9FJ0HL51 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.